Arrowhead Pharmaceuticals Inc (ARWR)
19.63
-0.12
(-0.61%)
USD |
NASDAQ |
Dec 24, 16:00
Arrowhead Pharmaceuticals Cash from Investing (Quarterly): -222.92M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | -128.82M |
| Amgen Inc | -210.00M |
| Vertex Pharmaceuticals Inc | -348.00M |
| Avidity Biosciences Inc | -482.41M |
| Harmony Biosciences Holdings Inc | 0.745M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -137.22M |
| Cash from Financing (Quarterly) | 389.09M |
| Free Cash Flow | -604.32M |
| Free Cash Flow Per Share (Quarterly) | -1.299 |
| Free Cash Flow Yield | -25.69% |